New advancements in the use of adult, embryonic stem cells for tissue regeneration

November 6, 2008,

A major issue in the development of regenerative medicine is the cell sources used to rebuild damaged tissues. In a review of the issue published in Developmental Dynamics, researchers state that inducing regeneration in humans from the body's own tissues by chemical means is feasible, though many questions must be answered before the process can reach clinical status.

Regeneration is a regulative developmental process ubiquitous across all species. It functions throughout the life cycle to maintain or restore the normal form and function of cells, tissues and, in some cases organs, appendages and whole organisms. The roots, stems and leaves of plants, for example, have extensive regenerative capacity, and entire plants can grow from single cells or small cuttings.

The regenerative capability of most vertebrate animals, however, is restricted to certain tissues. In the absence of injury, many cell types such as epithelia and blood cells turn over rapidly, while others such as hepatocytes, myofibers, osteocytes, and most neurons, have low turnover rates or do not turn over at all. In organisms that grow throughout life, such as fish, the total number of cells in various tissues increases continuously, indicating that the number of new cells produced is higher than the number of cells lost.

By contrast, the loss of normal tissue mass and/or architecture to acute injury or disease in humans requires a more intense and qualitatively different regenerative response that restores the tissue to its original state. This response is called injury-induced regeneration.

A major issue for cell transplant therapies is the source of the cells to be used. Three sources of cells can be tapped for transplant: differentiated tissues, adult stem cells (ASCs) and derivatives of embryonic stem cells (ESCs). Adult stem cells regenerate epithelia, brain tissue, muscle, blood and bone. They have also been found in other tissues that normally scar after injury, such as myocardium, spinal cord and retina tissues.

"Adult stem cell therapy has real potential to regenerate at least muscle and bone damaged by injury or genetic disease, and cardiac stem cells may be a way to regenerate new cardiomyocytes after myocardial infarction," says David L. Stocum, co-author of the paper.

Progress is also being made toward the use of ESCs to derive functional cells for treatment of diabetes and muscular dystrophy.

A procedure has been developed to direct the differentiation of human ESCs to pancreatic islet cells, including insulin producing cells. When implanted into mice, the cells produce human insulin in response to glucose stimulation and protect against hyperglycemia.

"ESCs show great promise as a cell source for the regeneration of new tissue, due to their high growth and self-renewal capacity, and their ability to differentiate into a myriad of precursor or differentiated cell types when directed by the appropriate set of environmental factors," says co-author Günther K.H. Zupanc.

The recently acquired ability to reprogram adult somatic cells to ESCs in culture ("induced pluripotent stem cells") has solved bioethical concerns surrounding the destruction of somatic cell nuclear transfer embryos to make personal embryonic stem cells that will not be immunorejected. The authors state, however, that induced pluripotent stem cells raise their own biological and bioethical issues. Biological issues include the differentiation and survival time of reprogrammed somatic cells, and the need to develop methods to reprogram cells without introducing exogenous DNA. Ethical issues, including cost, the ease of reprogramming for the purpose of conducting unethical experiments, like the derivation of human offspring, have yet to be resolved.

The ability to reprogram adult somatic cells to ESCs in culture has led the authors to the concept that it may be possible to use natural or synthetic molecules to reprogram adult somatic cells in vivo to adult stem cells that will recapitulate the development of a tissue, organ or appendage, or to stimulate resident adult stem cells to do so. They argue that strong regenerators, such as fish and amphibians know how to do this naturally, and should be studied to learn what molecules are required for such stimulation or reprogramming. The counterparts of these molecules, or synthetic small molecules that mimic their action, could then be applied to regeneration-deficient mammalian tissues.

Source: Wiley

Explore further: Cognitive benefits of 'young blood' linked to brain protein in mice

Related Stories

Cognitive benefits of 'young blood' linked to brain protein in mice

February 21, 2018
Loss of an enzyme that modifies gene activity to promote brain regeneration may be partly responsible for age-related cognitive decline, according to new research in laboratory mice by UC San Francisco scientists, who also ...

Researchers find adult endothelial stem cells that can make fully functional blood vessels

February 15, 2018
The proper function of blood vessels is essential to life: blood vessels are responsible for transporting oxygen-rich red blood cells, nutrients, and immune cells throughout the body, to name just a few functions. Defects ...

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Scientists produce human intestinal lining that re-creates living tissue inside organ-chip

February 16, 2018
Investigators have demonstrated how cells of a human intestinal lining created outside an individual's body mirror living tissue when placed inside microengineered Intestine-Chips, opening the door to personalized testing ...

Alzheimer's drug repairs brain damage after alcohol binges in rodents

February 15, 2018
A drug used to slow cognitive decline in Alzheimer's disease could offer clues on how drugs might one day be able to reverse brain changes that affect learning and memory in teens and young adults who binge drink.

Recommended for you

Low-calorie diet enhances intestinal regeneration after injury

February 22, 2018
Dramatic calorie restriction, diets reduced by 40 percent of a normal calorie total, have long been known to extend health span, the duration of disease-free aging, in animal studies, and even to extend life span in most ...

Artificial intelligence quickly and accurately diagnoses eye diseases and pneumonia

February 22, 2018
Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas, ...

Gut microbes protect against sepsis—mouse study

February 22, 2018
Sepsis occurs when the body's response to the spread of bacteria or toxins to the bloodstream damages tissues and organs. The fight against sepsis could get a helping hand from a surprising source: gut bacteria. Researchers ...

Fertility breakthrough: New research could extend egg health with age

February 22, 2018
Women have been told for years that if they don't have children before their mid-30s, they may not be able to. But a new study from Princeton University's Coleen Murphy has identified a drug that extends egg viability in ...

Breakthrough could lead to better drugs to tackle diabetes and obesity

February 22, 2018
Breakthrough research at Monash University has shown how different areas of major diabetes and obesity drug targets can be 'activated', guiding future drug development and better treatment of diseases.

Therapy for muscular dystrophy-caused heart failure also improves muscle function in mice

February 22, 2018
Injections of cardiac progenitor cells help reverse the fatal heart disease caused by Duchenne muscular dystrophy and also lead to improved limb strength and movement ability, a new study shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.